Tokyo Women's Medical University

What Tokyo Women's Medical University does

Tokyo Women's Medical University (TWMU) is a private educational corporation (学校法人) founded in 1900 by Yoshiyo Yoshioka as Japan's first women's medical school, headquartered in Shinjuku, Tokyo. TWMU operates a vertically integrated education-and-clinical platform comprising a 6-year School of Medicine, a 4-year School of Nursing, graduate programs in medicine and nursing, a 3-year Nursing Vocational School, and three affiliated tertiary-care hospitals: the main Tokyo Women's Medical University Hospital, the 450-bed Adachi Medical Center in east Tokyo (opened 2021), and the Yachiyo Medical Center in Chiba Prefecture. The university also operates the Institute of Advanced Biomedical Engineering (TWASK, producer of the Hyper SCOT smart surgical theater), the Institute of Oriental Medicine, and a Daito Campus in Shizuoka for first-year nursing students. Headcount is reported at 5,001–10,000.

Clinical differentiation is concentrated in three areas: kidney transplantation (~100 procedures annually, the highest volume in Japan, with a 95% 10-year graft survival rate and world-leading blood-incompatible transplant outcomes), ophthalmology (~2,000 anti-VEGF injections annually for age-related macular degeneration, the highest in Japan, using individualized OCT-monitored intervals), and respiratory medicine (lead site for the multi-center TERESA trial of tezepelumab in severe asthma, published 2026). Da Vinci robotic surgery, introduced in 2013, exceeds 100 kidney-cancer partial nephrectomies annually. Internationally, TWMU runs pediatric cardiac-surgery missions in Myanmar through partnerships with the National Cardiovascular Research Center and NPO Japan Heart, funded in part by the Akemi-chan Fund.

Revenue derives from three streams: (i) patient-care and medical services across the three affiliated hospitals; (ii) tuition and academic fees for medical, nursing, graduate, and vocational programs—reduced in June 2026 for the 2027 academic year; and (iii) government and industry research funding (e.g., JSPS KAKENHI grants, AstraZeneca-sponsored clinical trials). Capital expenditures are partly donor-funded through the 120th Anniversary Fundraising Campaign targeting 5 billion yen, supporting Kawada-cho campus redevelopment through year-end 2028.

Name

Tokyo Women's Medical University

Legal name

東京女子医科大学 (Tokyo Women's Medical University)

Website

https://twmu.ac.jp

Company type

Private

Founded year

1900

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Medical University and Tertiary Hospital Services

NAICS

General Medical and Surgical Hospitals (6221), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), General Medical and Surgical Hospitals (622110)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000)

akta.pro primary industry

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA)

akta.pro secondary industries

Medical Schools (MD/DO Granting) (EDAHAGAB), Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Medical education
• Clinical hospital services
• Nursing education
• Medical research
• Advanced specialty treatment

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient care and medical services: Revenue generated from medical services provided at affiliated hospitals (Tokyo Women's Medical University Hospital, Adachi Medical Center, Yachiyo Medical Center, and affiliated institutions). These include outpatient clinics, inpatient care, surgeries, diagnostic services, and specialized treatments.
2. Tuition and academic fees: Revenue from medical and nursing education programs including undergraduate tuition (医学部, 看護学部), graduate school tuition (医学研究科, 看護学研究科), and nursing vocational school tuition.
3. Research grants and contracts: Funding from government research programs including Japan Society for the Promotion of Science (JSPS) KAKENHI grants (科研費), and other competitive research funding. Also includes commissioned research from pharmaceutical companies such as AstraZeneca.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Tokyo Women's Medical University is a private Japanese educational corporation that provides medical and nursing education (undergraduate and graduate), operates three affiliated hospitals/medical centers delivering advanced tertiary and specialty clinical care, and conducts biomedical research through institutes including the Institute of Advanced Biomedical Engineering and Science (TWASK). Its hospital network performs high-volume specialty procedures including kidney transplantation, anti-VEGF ophthalmology therapy, and robotic surgery. Revenue is generated primarily from patient care at affiliated hospitals and tuition from medical/nursing students, supplemented by research grants and donations.

Product overview

東京女子医科大学は、建学精神「至誠と愛」のもとに、医学教育・看護教育を提供する総合医科大学グループである。主力产品は6年制医学部と4年制看護学部两大教育機関並びに従属する大学院（医学研究科学与看護学研究科）で、これに附属病院（东京女子医科大学病院）、足立医療センター、八千代医療センター、東洋医学研究所など系列医療機関が加わる。手術支援ロボット（ダビンチ）導入やHyper SCOT（Smart Cyber Operating Theater）の開発など、先端的医疗技术にも力を入れている。出品された大学見本市2026の出展予定Research活动中.

Differentiator

Problem solved

Functional benefit

Products and services

• School of Medicine (医学部) 6-year undergraduate medical education program aimed at training physicians. Covers all clinical departments including anatomy, physiology, internal medicine, and surgery. Delivered at the Kawada-cho campus with clinical training at affiliated hospitals.
• School of Nursing (看護学部) 4-year undergraduate nursing education program aimed at training nurses and public health nurses. Includes practice across nursing specialties from foundational nursing to community nursing. Delivered at the Kawada-cho and Daito campuses.
• Graduate School of Medicine (大学院医学研究科) Graduate program offering advanced medical research and awarding doctoral and master's degrees in medical sciences. Includes research across foundational and clinical medicine.
• Graduate School of Nursing (大学院看護学研究科) Graduate program offering nursing research education for master's (pre-doctoral) and doctoral (post-doctoral) courses.
• Tokyo Women's Medical University Hospital (附属病院) Main university hospital in Shinjuku, Tokyo, providing comprehensive advanced medical services across all clinical specialties including tertiary/quaternary care, emergency services, and specialized treatment centers (e.g., kidney transplantation, robotic surgery, anti-VEGF therapy).
• Adachi Medical Center (附属足立医療センター) University hospital branch in Adachi-ku, Tokyo, providing tertiary emergency, disaster base, cancer treatment, regional medical support, advanced acute care, and perinatal maternal/child medical services with 450 beds. Completed and opened July 2021.
• Yachiyo Medical Center (附属八千代医療センター) Affiliated medical center in Yachiyo City, Chiba Prefecture, providing regional healthcare services as part of the university's medical center network.
• Institute of Oriental Medicine (附属東洋医学研究所) Institute for research and clinical application of Oriental Medicine, including traditional Chinese/Kampo medicine practices.
• Nursing Vocational School (看護専門学校) 3-year vocational nursing school aimed at training nurses.
• Hyper SCOT (Smart Cyber Operating Theater) MRI-centric smart surgical suite system developed in-house by the Institute of Advanced Biomedical Engineering and Science (TWASK). Integrates approximately 20 types of medical equipment into a networked environment, aggregating intraoperative imaging, surgical instrument positions, and patient vital signs in real time. Features an intraoperative cockpit robotic arm that supports the surgeon's arm and a robotic surgical table that automatically transfers patients to intraoperative MRI. Received the 2016 Good Design Award. Deployed for precision surgery at the main hospital.
• Institute of Advanced Biomedical Engineering and Science (TWASK) University research institute engaged in advanced medical device research and development, including the Hyper SCOT smart surgical theater and other frontier biomedical technologies.
• da Vinci Surgical System robotic surgery program Robotic surgery program using the da Vinci Surgical System, primarily for kidney cancer partial nephrectomy. Introduced in 2013 and now performs 100+ cases annually, with expanding application into critical-care areas.

Quantifiable outcome

• 34.6% of patients with uncontrolled severe asthma achieved clinical remission at 52 weeks with tezepelumab (TERESA trial, 2026)
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Kyushu University Hospital (九州大学病院)coreStrategic or Co-development Partner · 1 January 2026Co-led the TERESA clinical trial (jRCTs071230026) — a world-first prospective multi-center interventional study evaluating tezepelumab for clinical remission in severe asthma across 24 Japanese facilities. Professor Isamu Okamoto from Kyushu University and Lecturer Keiko Kan-o from Tokyo Women's Medical University co-authored the study published in The Journal of Allergy and Clinical Immunology (2026). Funding provided by AstraZeneca.
• Progress in Neurobiology (journal)minorOthers · 1 January 2026Academic journal that published the university's research on thalamic neuron hyperexcitability mechanisms following peripheral nerve injury, related to neuropathic pain. Research was funded by JSPS KAKENHI grants and multiple Japanese foundations.
• National Cardiovascular Research Center (国立循環器病研究センター)coreStrategic or Co-development Partner · 1 January 2015Collaborates with Tokyo Women's Medical University in international medical aid projects, specifically in pediatric cardiac surgery missions. Center provides pediatric cardiac surgery expertise while the university contributes medical staff for training and treatment programs in developing countries such as Myanmar.
• NPO Japan Heart (法人ジャパンハート)coreStrategic or Co-development Partner · 1 January 2015Partners with the university in international medical aid projects, particularly cardiac treatment missions to Myanmar. Japan Heart provides operational infrastructure for international medical missions while the university provides specialized medical expertise.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Tokyo Medical and Dental University: National medical university with a major affiliated hospital. Comparable as a top-tier Japanese academic medical center, though funded as a public institution rather than a private 学校法人.
• The University of Tokyo Hospital: Japan's flagship public academic medical center. Comparable as an academic medical center with advanced specialty care and research, but with substantially larger scale and public-institution funding model.

Direct peers

• Juntendo University: Private Japanese medical university with multiple affiliated hospitals. Closely comparable to TWMU in mission (private medical education + hospital network) and Tokyo-centric patient/service catchment.
• Nippon Medical School: Tokyo-based private medical university operating multiple affiliated hospitals. Comparable in scale, mission, and reliance on hospital-network economics; competes directly with TWMU for students and specialty talent.
• St. Marianna University School of Medicine: Private Japanese medical university with a teaching hospital. Comparable as a private medical education provider with affiliated hospital and graduate programs, in the Kanto region.
• Keio University School of Medicine: Major private Japanese medical university with a teaching hospital and broad research portfolio. Directly comparable to TWMU as a private-sector peer competing for students, research grants, and clinical talent in Tokyo.
• Teikyo University: Large private Japanese medical university with affiliated hospitals. Comparable multi-hospital model, research footprint, and reliance on tuition and clinical revenue.
• Kitasato University: Private Japanese medical university with a large hospital network. Comparable in mission, multi-hospital structure, and research focus areas that overlap with TWMU's specialty centers.

Regional players

• Kyoto Prefectural University of Medicine: Public medical university with a major affiliated hospital. Comparable as an academic medical center, but Kansai-based and publicly funded, so not a direct head-to-head competitor in Tokyo.
• Osaka Medical and Pharmaceutical University: Private Japanese medical university combining medical and pharmaceutical education with a teaching hospital. Comparable in mission and structure, but operates primarily in the Kansai region rather than competing directly in Tokyo.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@TokyoWomensMedicalUniversity

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tokyo Women's Medical University